ArmaVir Partners

NJOY, Inc. is a manufacturer and distributor of electronic cigarettes and vaping products, offering both rechargeable and non-rechargeable options. Established in 2006 and headquartered in Scottsdale, Arizona, the company has positioned itself as a pioneer in the vaping industry, aiming to provide adult smokers with alternatives to traditional combustible cigarettes. NJOY's product range includes non-rechargeable electronic cigarette packs, rechargeable starter kits complete with batteries and cartridge refills, disposable electronic cigarettes, and various accessories like chargers. The company markets its products through an extensive network, including online platforms and retail locations such as convenience stores, effectively reaching customers across all 50 states. With additional offices in New York City, NJOY continues to innovate within the vaping sector, contributing to its significant growth.

CALDER GROUP specializes in precision engineering and manufacturing engineered components for various industries, including aerospace and defense, marine, nuclear, and oil and gas. The company produces lead and bronze engineered products, as well as complex precision-engineered components designed for mission-critical applications. Additionally, CALDER GROUP offers nuclear shielding, containment, and remote handling equipment, ensuring reliability and safety across its diverse market sectors. Their commitment to high-quality engineering solutions addresses the specific needs of clients in construction, healthcare, security, and other fields.

PAX Labs, Inc. is a manufacturer of premium vaporizers and accessories designed for loose-leaf and concentrates. The company's product lineup includes the PAX 3, PAX 2, and PAX Era, along with various accessories and a mobile application that enhances user experience. PAX Labs aims to simplify cannabis consumption by providing products that emphasize quality, transparency, and predictability. The company distributes its products through a network of retailers and distributors across the United States and internationally, as well as through its online platform. Founded in 2004 and headquartered in San Francisco, California, PAX Labs has established itself as an industry leader through innovation and thoughtful product design.

NJOY, Inc. is a manufacturer and distributor of electronic cigarettes and vaping products, offering both rechargeable and non-rechargeable options. Established in 2006 and headquartered in Scottsdale, Arizona, the company has positioned itself as a pioneer in the vaping industry, aiming to provide adult smokers with alternatives to traditional combustible cigarettes. NJOY's product range includes non-rechargeable electronic cigarette packs, rechargeable starter kits complete with batteries and cartridge refills, disposable electronic cigarettes, and various accessories like chargers. The company markets its products through an extensive network, including online platforms and retail locations such as convenience stores, effectively reaching customers across all 50 states. With additional offices in New York City, NJOY continues to innovate within the vaping sector, contributing to its significant growth.

Bluebird bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on researching, developing, and commercializing gene therapies for severe genetic diseases and cancer. The company's gene therapy programs include LentiGlobin, aimed at treating β-thalassemia and sickle cell disease, and Lenti-D for cerebral adrenoleukodystrophy. In oncology, bluebird bio is developing chimeric antigen receptor T (CAR T) cell therapies, specifically bb2121 and bb21217, for multiple myeloma. The company has formed strategic collaborations with several organizations, including Bristol-Myers Squibb and Regeneron Pharmaceuticals, to advance gene therapies in oncology and immune cell therapies. Additionally, bluebird bio collaborates with various partners to explore T cell receptor product candidates and in vivo genome editing treatments for genetic disorders. Established in 1992 and originally known as Genetix Pharmaceuticals, the company transitioned to its current name in 2010.

Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing innovative therapeutic products for cancer treatment. The company's lead product candidate, tucatinib, is an oral, HER2-selective small molecule tyrosine kinase inhibitor currently undergoing two Phase Ib clinical trials for metastatic breast cancer in combination therapies. In addition to tucatinib, Cascadian Therapeutics is advancing its preclinical pipeline, which includes CASC-578, a Chk1 cell cycle inhibitor, and CASC-674, an antibody targeting immuno-oncology. The company has established collaborative agreements with Array BioPharma for tucatinib development, Sentinel Oncology for novel Chk1 inhibitors, and Adimab for discovering new antibodies targeting immunotherapy in oncology. Founded in 1985 and formerly known as Oncothyreon Inc., Cascadian Therapeutics continues to focus on providing targeted therapies that aim to improve cancer treatment outcomes.

Biomoda, Inc. is a development stage company based in Albuquerque, New Mexico, focused on in-vitro diagnostics, particularly in the detection of cancer. The company is advancing its key product, CyPath, an assay designed to identify early-stage lung cancer through a non-invasive method. This diagnostic test utilizes a patented porphyrin application that selectively binds to cancerous cells in deep-lung sputum samples. In addition to lung cancer, Biomoda is exploring diagnostic protocols for other types of cancer, including breast and prostate cancer. The company collaborates with the New Mexico Institute of Mining and Technology for clinical studies aimed at early lung cancer detection among veterans. Furthermore, Biomoda has partnered with Medical Acoustics, LLC for the use of its Lung Flute device in sample collection, and has secured consulting agreements to navigate the FDA approval process. Founded in 1990, Biomoda is committed to developing innovative solutions for cancer detection.

SinoHub, Inc. is an electronics company based in Shenzhen, China, operating in two main segments: Integrated Contract Manufacturing (ICM) and Electronic Component Sales and Services (ECSS). The ICM segment specializes in custom, private label mobile phones and tablets, primarily targeting customers in developing countries. Meanwhile, the ECSS segment focuses on the sale of electronic components to manufacturers and design houses, as well as providing comprehensive supply chain management services, which encompass warehousing, logistics, delivery, and import/export operations. Additionally, SinoHub offers a proprietary web-based software platform that facilitates the management of electronic component procurement and logistics, providing functionalities such as order entry, inventory management, and shipment tracking. Founded in 2000, SinoHub serves a diverse clientele, including original equipment manufacturers (OEMs) and electronic manufacturing services (EMS) companies.

CEL-SCI Corporation is a biotechnology company based in Vienna, Virginia, that focuses on the research and development of immunotherapy products for cancer and infectious diseases. Its leading investigational therapy, Multikine, is currently undergoing phase III clinical trials for treating head and neck cancer. Additionally, CEL-SCI has developed a proprietary platform known as the Ligand Epitope Antigen Presentation System (LEAPS), which aims to enhance the human immune response against various health issues, including bacterial, viral, and parasitic infections, as well as autoimmune diseases and cancer. The company is also exploring other product candidates, such as LEAPS-H1N1-DC for influenza, CEL-2000 and CEL-4000 for rheumatoid arthritis, and LEAPS COV-19 for COVID-19. CEL-SCI collaborates with the University of Georgia’s Center for Vaccines and Immunology to advance its COVID-19 immunotherapy efforts. Founded in 1983, CEL-SCI continues to innovate in the biopharmaceutical sector.

BravoSolution SpA specializes in supply management technology software and services aimed at enhancing procurement and sourcing processes. The company provides a range of solutions, including Spend Analysis to optimize savings and compliance, eSourcing for collaborative sourcing efforts, and supplier performance management tools. Its Contract Management service streamlines contract processes to ensure users realize savings from their negotiations. Notable products include BravoAlign, a cloud-based procurement alignment solution, and BravoAdvantage, a comprehensive platform that supports procurement initiatives from demand to contract. Additionally, BravoAdvantage Analytics offers data visualization tools, enabling procurement professionals to create intuitive reports and dashboards. BravoSolution also delivers collaboration services and government solutions related to spend visibility and electronic sourcing. Founded in 2000 and headquartered in Milan, Italy, BravoSolution operates offices in multiple countries, including the United States, Brazil, and several European nations. As of late 2017, it functions as a subsidiary of JAGGAER, Inc.

EarlyBirdCapital, Inc. is a registered broker-dealer and boutique investment banking firm located in New York City, established in 2000. The firm specializes in providing investment banking services to smaller capitalization companies and focuses on equity offerings, private placements, public offerings, mergers and acquisitions, debt placements, and valuation services. EarlyBirdCapital has developed significant expertise in Special Purpose Acquisition Companies (SPACs), serving as an underwriter for SPAC initial public offerings. The firm is a member of several regulatory bodies, including the Financial Industry Regulatory Authority and the Municipal Securities Rulemaking Board, ensuring compliance and oversight in its operations.

ci4net.com is a European economic network, or "Econet". The Company currently owns 50% or more of 26 Internet companies involved in Business-to-Business, Business-to-Consumer, e-Commerce and infrastructure. ci4net.com is focused on adding value at all stages of a company's development via its network. ci4net.com can provide infrastructure technologies, operational and management resources and synergistic access to a network of portfolio companies.

Xceed has been creating top-of-the-line software components for nearly 20 years. Their current product line boasts over 135 professional components, which are used by more than 100,000 professional developers worldwide, including Microsoft in applications such as Visual Studio 2010 and 2012 and Microsoft Office. Their focus is on creating and marketing UI controls that help developers and designers create a compelling user experience (UX) with the Windows Presentation Foundation (WPF), the backbone of LOB solutions. Xceed DataGrid for WPF is their flagship product. Their extensive offering also includes some of the most popular UI controls and data manipulation libraries for .NET (such as Zip and FTP), as well as controls and libraries for Silverlight, Windows Phone, and ActiveX/COM.